Sirnaomics Ltd. (2257.HK)
HKD 3.58
(-0.56%)
HKD 3.58
(-0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -70.29 Million | -88.7 Million | -56.97 Million | -18.99 Million | -14.4 Million |
| Net Income | -84.99 Million | -97.37 Million | -215.93 Million | -46.42 Million | -17.12 Million |
| Depreciation & Amortization | 6.15 Million | 3.93 Million | 1.63 Million | 1.04 Million | 824 Thousand |
| Deferred income taxes | - | 6.11 Million | -315 Thousand | -633 Thousand | -120 Thousand |
| Stock-based compensation | 3.55 Million | 413 Thousand | 11.28 Million | 992 Thousand | 578 Thousand |
| Change in working capital | -2.74 Million | -1.23 Million | -476 Thousand | -150 Thousand | -1.27 Million |
| Other non-cash items | -2.04 Million | -555 Thousand | 146.84 Million | 26.17 Million | 2.71 Million |
| Investing Cash Flow | -5.35 Million | -32.61 Million | -6.03 Million | 8.39 Million | 1.1 Million |
| Investments in PPE | -1.74 Million | -18.83 Million | -5.87 Million | -2.15 Million | -1.18 Million |
| Acquisitions | - | 1.35 Million | -576 Thousand | -10.44 Million | -28 Thousand |
| Investment purchases | -13.17 Million | -33.62 Million | -170.98 Million | -78.36 Million | -1.51 Million |
| Sales/Maturities of investments | 8.39 Million | 18.66 Million | 171.29 Million | 88.83 Million | 3.76 Million |
| Other Investing Activities | 174 Thousand | -179 Thousand | 103 Thousand | 10.52 Million | 67 Thousand |
| Financing Cash Flow | -5.6 Million | 15.88 Million | 170.96 Million | 100.36 Million | 11.54 Million |
| Debt repayment | -812 Thousand | -3.33 Million | -96.47 Million | -1.16 Million | -403 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -6.48 Million | -10.21 Million | - | -614 Thousand | -115 Thousand |
| Common Stock Issuance | 1.05 Million | 10.28 Million | 63.87 Million | 655 Thousand | 174 Thousand |
| Other Financing Activities | 894 Thousand | 15.81 Million | 203.55 Million | 100.32 Million | 11.48 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | -2.78 Million | -1.23 Million | -476 Thousand | -150 Thousand | -1.27 Million |
| Cash at beginning of period | 105.22 Million | 211.99 Million | 103.12 Million | 9.94 Million | 11.68 Million |
| Cash at end of period | 23.88 Million | 105.22 Million | 211.99 Million | 103.12 Million | 9.94 Million |
| Capital Expenditure | -1.74 Million | -18.83 Million | -5.87 Million | -2.15 Million | -1.18 Million |
| Effect of forex changes on cash | -97 Thousand | -1.33 Million | 916 Thousand | 3.41 Million | 16 Thousand |
| Net cash flow / Change in cash | -81.34 Million | -106.76 Million | 108.87 Million | 93.17 Million | -1.73 Million |
| Free Cash Flow | -72.03 Million | -107.53 Million | -62.84 Million | -21.14 Million | -15.59 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -84.99 Million | - | - | - | -97.37 Million | - |
| Depreciation & Amortization | 6.15 Million | - | - | - | 3.93 Million | - |
| Deferred income taxes | - | - | - | - | 6.11 Million | - |
| Stock-based compensation | 3.55 Million | - | - | - | 413 Thousand | - |
| Change in working capital | -2.74 Million | - | - | - | -1.23 Million | - |
| Other non-cash items | -2.04 Million | - | - | - | -555 Thousand | - |
| Investing Cash Flow | -5.35 Million | - | - | - | -32.61 Million | - |
| Investments in PPE | -1.74 Million | - | - | - | -18.83 Million | - |
| Acquisitions | - | - | - | - | 1.35 Million | - |
| Investment purchases | -13.17 Million | - | - | - | -33.62 Million | - |
| Sales/Maturities of investments | 8.39 Million | - | - | - | 18.66 Million | - |
| Other Investing Activities | 174 Thousand | - | - | - | -179 Thousand | - |
| Financing Cash Flow | -5.6 Million | - | - | - | 15.88 Million | - |
| Debt repayment | -812 Thousand | - | - | - | -3.33 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -6.48 Million | - | - | - | -10.21 Million | - |
| Common Stock Issuance | 1.05 Million | - | - | - | 10.28 Million | - |
| Other Financing Activities | 894 Thousand | - | - | - | 15.81 Million | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.78 Million | - | - | - | -1.23 Million | - |
| Cash at beginning of period | 105.22 Million | - | - | - | 211.99 Million | - |
| Cash at end of period | 23.88 Million | - | - | - | 105.22 Million | - |
| Capital Expenditure | -1.74 Million | - | - | - | -18.83 Million | - |
| Effect of forex changes on cash | -97 Thousand | - | - | - | -1.33 Million | - |
| Net cash flow / Change in cash | -81.34 Million | - | - | - | -106.76 Million | - |
| Free Cash Flow | -72.03 Million | - | - | - | -107.53 Million | - |
RWI
9958
SFBTF
VRG
ESSARSHPNG
CPOUF